Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Digestive System Neoplasms 3Digestive System Diseases 3Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Stomach Neoplasms 1Stomach Diseases 1Rectal Diseases 1Pancreatic Neoplasms 1Pancreatic Diseases 1Intestinal Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Esophageal Diseases 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Colorectal Neoplasms 1Colonic Diseases 1

Interventions

Gemcitabine 5Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4selpercatinib 2napabucasin 2entinostat 2Irinotecan 2repotrectinib 1pralsetinib 1pembrolizumab 1lutetium Lu 177 dotatate 1irinotecan sucrosofate 1ganitumab 1copper dotatate CU-64 1Therapeutic Irrigation 1Taxes 1Sunitinib 1Paclitaxel 1Oxaliplatin 1Ocoxin 1Lutetium-177 1Lutetium 1Leucovorin 1Fluorouracil 1Denosumab 1Cisplatin 1Capecitabine 1Blood Specimen Collection 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endocrine Gland Neoplasms × Ocoxin × Gastrointestinal × Clear all
NCT03717298 2023-03-28

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Catalysis SL

Phase 2 Completed
30 enrolled
Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡